25.07.2021 Views

Microbiology, 2021

Microbiology, 2021

Microbiology, 2021

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

966 23 • Urogenital System Infections<br />

CHECK YOUR UNDERSTANDING<br />

• Why are latent herpes virus infections still of clinical concern?<br />

• How is neonatal herpes contracted?<br />

Human Papillomas<br />

Warts of all types are caused by a variety of strains of human papillomavirus (HPV) (see Viral Infections of the<br />

Skin and Eyes). Condylomata acuminata, more commonly called genital warts or venereal warts (Figure<br />

23.18), are an extremely prevalent STI caused by certain strains of HPV. Condylomata are irregular, soft, pink<br />

growths that are found on external genitalia or the anus.<br />

HPV is a small, non-enveloped virus with a circular double-stranded DNA genome. Researchers have identified<br />

over 200 different strains (called types) of HPV, with approximately 40 causing STIs. While some types of HPV<br />

cause genital warts, HPV infection is often asymptomatic and self-limiting. However, genital HPV infection<br />

often co-occurs with other STIs like syphilis or gonorrhea. Additionally, some forms of HPV (not the same ones<br />

associated with genital warts) are associated with cervical cancers. At least 14 oncogenic (cancer-causing) HPV<br />

types are known to have a causal association with cervical cancers. Examples of oncogenic HPV are types 16<br />

and 18, which are associated with 70% of cervical cancers. 12 Oncogenic HPV types can also cause<br />

oropharyngeal cancer, anal cancer, vaginal cancer, vulvar cancer, and penile cancer. Most of these cancers are<br />

caused by HPV type 16. HPV virulence factors include proteins (E6 and E7) that are capable of inactivating<br />

tumor suppressor proteins, leading to uncontrolled cell division and the development of cancer.<br />

HPV cannot be cultured, so molecular tests are the primary method used to detect HPV. While routine HPV<br />

screening is not recommended for men, it is included in guidelines for women. An initial screening for HPV at<br />

age 30, conducted at the same time as a Pap test, is recommended. If the tests are negative, then further HPV<br />

testing is recommended every five years. More frequent testing may be needed in some cases. The protocols<br />

used to collect, transport, and store samples vary based on both the type of HPV testing and the purpose of the<br />

testing. This should be determined in individual cases in consultation with the laboratory that will perform the<br />

testing.<br />

Because HPV testing is often conducted concurrently with Pap testing, the most common approach uses a<br />

single sample collection within one vial for both. This approach uses liquid-based cytology (LBC). The samples<br />

are then used for Pap smear cytology as well as HPV testing and genotyping. HPV can be recognized in Pap<br />

smears by the presence of cells called koilocytes (called koilocytosis or koilocytotic atypia). Koilocytes have a<br />

hyperchromatic atypical nucleus that stains darkly and a high ratio of nuclear material to cytoplasm. There is a<br />

distinct clear appearance around the nucleus called a perinuclear halo (Figure 23.19).<br />

12 Lauren Thaxton and Alan G. Waxman. “Cervical Cancer Prevention: Immunization and Screening 2015.” Medical Clinics of North<br />

America 99, no. 3 (2015): 469–477.<br />

Access for free at openstax.org.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!